849189450	849189450	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
53265193	53265193	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
992856	992856	CD	B-NP	O
|	|	CC	I-NP	O
9/18/1995	9/18/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/12/1995	2/12/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/10/1995	3/10/1995	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rhalca	Rhalca	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
four-year	four-year	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left-sided	left-sided	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
occurring	occur	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
q.	q.	RB	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
noted	note	VBN	I-NP	O
picture	picture	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ETT	ETT	NN	B-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
described	describe	VBD	B-VP	O
progressively	progressively	RB	B-NP	O
poor	poor	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
sublingual	sublingual	JJ	B-NP	O
NTG	NTG	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
twice	twice	RB	I-NP	O
daily	daily	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
severe	severe	JJ	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
sublingual	sublingual	JJ	I-NP	O
NTG	NTG	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
reported	report	VBD	B-VP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
seconds	second	NNS	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Spena	Spena	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
EMT	EMT	NN	I-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
intravenous	intravenous	JJ	B-NP	O
NTG	NTG	NN	I-NP	O
,	,	,	I-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
Diltiazem	Diltiazem	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ETT	ETT	NNP	I-NP	O
Thallium	Thallium	NNP	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
reperfusion	reperfusion	NN	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
anterior	anterior	JJ	I-NP	O
walls	wall	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
left	leave	VBD	B-VP	O
the	the	DT	B-NP	O
Ca	Ca	NNP	I-NP	O
Awythe	Awythe	NNP	I-NP	O
Stosit	Stosit	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
AMA	AMA	NNP	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
11th	11th	NN	I-NP	O
who	who	WP	B-NP	O
referred	refer	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Troydale	Troydale	NNP	I-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
he	he	PRP	B-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
notably	notably	RB	B-ADVP	O
an	an	DT	B-NP	O
80-pack	80-pack	JJ	I-NP	O
year	year	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
and	and	CC	O	O
non	non	JJ	B-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
interstitial	interstitial	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
GE	GE	NNP	B-NP	O
reflux	reflux	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
:	:	:	O	O
Cardizem	Cardizem	NNP	B-NP	O
120mg	120mg	CD	B-NP	O
p.o.b.i.d.	p.o.b.i.d.	NN	I-NP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
p.o.b.i.d.	p.o.b.i.d.	NNP	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
40mg	40mg	FW	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
,	,	,	I-NP	O
Ventolin	Ventolin	NN	I-NP	B-protein
and	and	CC	I-NP	O
Seldane	Seldane	NN	I-NP	O
taken	take	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prn	prn	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Six	Six	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
of	of	IN	B-PP	O
JVD	JVD	NN	B-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
with	with	IN	B-PP	O
intact	intact	JJ	B-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Diminished	Diminish	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EVALUATION	EVALUATION	NN	I-NP	O
:	:	:	O	O
Unremarkable	Unremarkable	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
main	main	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
with	with	IN	B-PP	O
additional	additional	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
midportion	midportion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
midportion	midportion	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
proximal	proximal	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
FEV-1	FEV-1	NN	I-NP	O
of	of	IN	B-PP	O
2.53	2.53	CD	B-NP	O
,	,	,	O	O
FEV-1	FEV-1	NN	B-NP	O
/	/	SYM	I-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
,	,	,	O	O
FVC	FVC	NN	B-NP	O
3.05	3.05	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
preoperatively	preoperatively	RB	B-ADVP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Dental	Dental	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
of	of	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
#	#	#	I-NP	O
32	32	CD	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
penicillin	penicillin	NN	I-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
and	and	CC	O	O
completed	complete	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
13	13	CD	I-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
double	double	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
including	include	VBG	B-PP	O
pedicle	pedicle	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
bypass	bypass	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
patch	patch	NN	I-NP	O
angioplasty	angioplasty	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
aortocoronary	aortocoronary	JJ	I-NP	O
saphenous	saphenous	JJ	I-NP	O
vein	vein	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
in	in	IN	B-PP	O
routine	routine	JJ	B-NP	O
fashion	fashion	NN	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
somewhat	somewhat	RB	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
normal	normal	JJ	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
which	which	WDT	B-NP	O
diminished	diminish	VBD	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
proceeded	proceed	VBD	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
a	a	DT	B-NP	O
low-grade	low-grade	JJ	I-NP	O
fever	fever	NN	I-NP	O
and	and	CC	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empiric	empiric	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
cefuroxime	cefuroxime	NN	B-NP	O
for	for	IN	B-PP	O
radiographic	radiographic	JJ	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
although	although	IN	B-SBAR	O
his	his	PRP$	B-NP	B-cell_line
sputum	sputum	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
not	not	RB	O	O
definitive	definitive	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ID	ID	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
cultured	culture	VBN	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
with	with	IN	B-PP	O
continuation	continuation	NN	B-NP	O
of	of	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
demonstate	demonstate	VB	I-VP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
to	to	TO	B-PP	O
16K	16K	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
definite	definite	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
wound	wound	NN	I-NP	O
sites	site	NNS	I-NP	O
looked	look	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
and	and	CC	O	O
cultures	culture	NNS	B-NP	O
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
oxygen	oxygen	NN	B-NP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
28	28	CD	I-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
we	we	PRP	B-NP	O
discharged	discharge	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
AMA	AMA	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
encouraged	encourage	VBD	B-VP	O
a	a	DT	B-NP	O
stay	stay	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325mg	325mg	NN	I-NP	O
q.d.	q.d.	NNP	B-NP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
120mg	120mg	CD	I-NP	O
p.o.t.i.d.	p.o.t.i.d.	NNP	I-NP	O
,	,	,	I-NP	O
Colace	Colace	NNP	I-NP	O
100mg	100mg	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
300mg	300mg	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80mg	80mg	CD	I-NP	O
p.o.b.i.d.	p.o.b.i.d.	NNP	I-NP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
p.o.b.i.d.	p.o.b.i.d.	NNP	I-NP	O
,	,	,	O	O
MVI	MVI	NNP	B-NP	O
one	one	CD	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
one	one	CD	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
.	.	.	O	O

q.	q.	LS	B-NP	O
4	4	CD	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
40mil/eq	40mil/eq	NN	I-NP	O
p.o.b.i.d.	p.o.b.i.d.	NN	I-NP	O
and	and	CC	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
p.o.b.i.d.	p.o.b.i.d.	NN	I-NP	O
X	X	SYM	B-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
taken	take	VBN	B-VP	O
with	with	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
300mg	300mg	CD	I-NP	O
p.o.q.i.d.	p.o.q.i.d.	FW	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
for	for	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Donnie	Donnie	NNP	I-NP	O
Daidone	Daidone	NNP	I-NP	O
office	office	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
interval	interval	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
completion	completion	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
HARLEY	HARLEY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
ARNOLD	ARNOLD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AC13	AC13	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ALEXIS	ALEXIS	NNP	B-NP	O
E.	E.	NNP	I-NP	O
NEWBROUGH	NEWBROUGH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JU9	JU9	NNP	I-NP	O
IF181/8678	IF181/8678	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
45688	45688	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

JUGEYG102W	JUGEYG102W	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/12/95	5/12/95	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/12/95	5/12/95	CD	B-NP	O

